Serotonergic neurotransmission plays a major role in the action of the glycogenic convulsant methionine sulfoximine

Neuroscience Research

Volumn 70, Issue 3, 2011, Pages 313-320

  Picard, M ^a   Cloix, J F ^a   Hevor, T K ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Dopamine; Epilepsy; Glycogen; Noradrenaline; Serotonin; Tryptophan

Indexed keywords

GLYCOGEN; METHIONINE SULFOXIMINE; SEROTONIN; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CARBOHYDRATE METABOLISM; CBA MOUSE; CONTROLLED STUDY; DISEASE MODEL; EPILEPSY; MALE; MOUSE; MOUSE STRAIN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SEROTONIN BRAIN LEVEL;

ANIMALS; CONVULSANTS; EPILEPSY; GLYCOGEN; MALE; METHIONINE SULFOXIMINE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 79957611888     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2011.03.002     Document Type: Article

References (48)

1. Avanzini G., Engel J., Fariello R., Heinemann U. Neurotransmitters in Epilepsy 1992, Elsevier, Amsterdam.
2. Bernard-Helary K., Ardourel M.Y., Hevor T., Cloix J.F. In vivo and in vitro glycogenic effects of methionine sulfoximine are different in two inbred strains of mice. Brain Res. 2002, 929:147-155.
3. Bidmon H.J., Gorg B., Palomero-Gallagher N., Schleicher A., Haussinger D., Speckmann E.J., Zilles K. Glutamine synthetase becomes nitrated and its activity is reduced during repetitive seizure activity in the pentylentetrazole model of epilepsy. Epilepsia 2008, 49:1733-1748.
4. Bidmon H.J., Gorg B., Palomero-Gallagher N., Schliess F., Gorji A., Speckmann E.J., Zilles K. Bilateral, vascular and perivascular glial upregulation of heat shock protein-27 after repeated epileptic seizures. J. Chem. Neuroanat. 2005, 30:1-16.
5. Blin M., Crusio W.E., Hevor T., Cloix J.F. Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice. Brain Res. Bull. 2002, 57:11-15.
6. Chugani H.T., Chugani D.C. Imaging of serotonin mechanisms in epilepsy. Epilepsy Curr. 2005, 5:201-206.
7. Cloix J.F., Hevor T. Epilepsy, regulation of brain energy metabolism and neurotransmission. Curr. Med. Chem. 2009, 16:841-853.
8. Cloix J.F., Tahi Z., Martin B., Hevor T. Selection of two lines of mice based on latency to onset of methionine sulfoximine seizures. Epilepsia 2010, 51:118-128.
9. Cremer C.M., Bidmon H.J., Gorg B., Palomero-Gallagher N., Escobar J.L., Speckmann E.J., Zilles K. Inhibition of glutamate/glutamine cycle in vivo results in decreased benzodiazepine binding and differentially regulated GABAergic subunit expression in the rat brain. Epilepsia 2010, 51:1446-1455.
10. Dalsgaard M.K., Madsen F.F., Secher N.H., Laursen H., Quistorff B. High glycogen levels in the hippocampus of patients with epilepsy. J. Cereb. Blood Flow Metab. 2007, 27:1137-1141.
11. Darvesh A.S., Gudelsky G.A. Activation of 5-HT2 receptors induces glycogenolysis in the rat brain. Eur. J. Pharmacol. 2003, 464:135-140.
12. Delgado-Escueta A.V. Advances in lafora progressive myoclonus epilepsy. Curr. Neurol. Neurosci. Rep. 2007, 7:428-433.
13. Delorme P., Hevor T.K. Glycogen particles in methionine sulfoximine epileptogenic rodent brain and liver after the administration of methionine and actinomycin D. Neuropathol. Appl. Neurobiol. 1985, 11:117-128.
14. Duncan J. The current status of neuroimaging for epilepsy. Curr. Opin. Neurol. 2009, 22:179-184.
15. Engel J., Brown W.J., Kuhl D.E., Phelps M.E., Mazziotta J.C., Crandall P.H. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann. Neurol. 1982, 12:518-528.
16. Engel J., Henry T.R., Risinger M.W., Mazziotta J.C., Sutherling W.W., Levesque M.F., Phelps M.E. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology 1990, 40:1670-1677.
17. Feria-Velasco A., Mena-Munguia S., Carabez-Torres J., Gomez-Medrano A., Recendiz-Hurtado F., Orozco-Suarez S., Beas-Zarate C. Low tryptophan and protein in the diet during development increase the susceptibility to convulsions in adult rats. Neurochem. Res. 2008, 33:1484-1491.
18. Folbergrova J., Passonneau J.V., Lowry O.H., Schulz D.W. Glycogen, ammonia and related metabolities in the brain during seizures evoked by methionine sulphoximine. J. Neurochem. 1969, 16:191-203.
19. Fonnum F., Paulsen R.E. Comparison of transmitter amino acid levels in rat globus pallidus and neostriatum during hypoglycemia or after treatment with methionine sulfoximine or gamma-vinyl gamma-aminobutyric acid. J. Neurochem. 1990, 54:1253-1257.
20. Ginefri-Gayet M., Gayet J. Involvement of serotonin receptors in methionine sulfoximine-induced hypothermia in the rat. Eur. J. Pharmacol. 1992, 217:85-91.
21. Ginefri-Gayet M., Gayet J. Possible link between brain serotonin metabolism and methionine sulfoximine-induced hypothermia and associated behavior in the rat. Pharmacol. Biochem. Behav. 1992, 43:173-179.
22. Ginefri-Gayet M., Gayet J. Hypothermia induced by infusion of methionine sulfoximine into the dorsal raphe nucleus of the rat: involvement of 5-HT1A and GABAB receptors. Eur. J. Pharmacol. 1993, 235:189-196.
23. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 1966, 13:655-669.
24. Hevor T., Gayet J. Stimulation of fructose-1,6-biphosphatase activity and synthesis in the cerebral cortex of rats submitted to the convulsant methionine sulfoximine. J. Neurochem. 1981, 36:949-958.
25. Hevor T.K. Methionine sulfoximine has no major effect on gamma aminobutyric acid concentration in the rat brain. Biogenic Amines 1996, 12:445-461.
26. Hevor T.K., Delorme P. Biochemical and ultrastructural study of glycogen in cultured astrocytes submitted to the convulsant methionine sulfoximine. Glia 1991, 4:64-69.
27. Hevor T.K., Delorme P., Beauvillain J.C. Glycogen synthesis and immunocytochemical study of fructose-1,6-biphosphatase in methionine sulfoximine epileptogenic rodent brain. J. Cereb. Blood Flow Metab. 1986, 6:292-297.
28. Hyder F. Dynamic imaging of brain function. Methods Mol. Biol. 2009, 489:3-21.
29. la Fougere C., Rominger A., Forster S., Geisler J., Bartenstein P. PET and SPECT in epilepsy: a critical review. Epilepsy Behav. 2009, 15:50-55.
30. Lei H., Morgenthaler F., Yue T., Gruetter R. Direct validation of in vivo localized 13C MRS measurements of brain glycogen. Magn. Reson. Med. 2007, 57:243-248.
31. Leon-Henri B., Gayet J. Intranigral methionine sulfoximine induces turning behaviour in the rat. Brain Res. 1984, 291:197-199.
32. Li B., Zhang S., Li M., Hertz L., Peng L. Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. Psychopharmacology (Berlin) 2009, 207:1-12.
33. Liew C.J., Lim Y.M., Bonwetsch R., Shamim S., Sato S., Reeves-Tyer P., Herscovitch P., Dustin I., Bagic A., Giovacchini G., Theodore W.H. 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy. Epilepsia 2009, 50:234-239.
34. Morgenthaler F.D., Lanz B.R., Petit J.M., Frenkel H., Magistretti P.J., Gruetter R. Alteration of brain glycogen turnover in the conscious rat after 5h of prolonged wakefulness. Neurochem. Int. 2009, 55:45-51.
35. Pachmerhiwala R., Bhide N., Straiko M., Gudelsky G.A. Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain. Eur. J. Pharmacol. 2010, 644:67-72.
36. Pennington A.J., Pentreath V.W. Transmitter-induced glycogenolysis and gluconeogenesis in leech segmental ganglia. J. Physiol. (Paris) 1987, 82:218-228.
37. Peters E.L., Tower D.B. Glutamic acid and glutamine metabolism in cerebral cortex after seizures induced by methionine sulphoximine. J. Neurochem. 1959, 5:80-90.
38. Poblete J.C., Azmitia E.C. Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor. Brain Res. 1995, 680:9-15.
39. Pranzatelli M.R., Tate E., Huang Y., Haas R.H., Bodensteiner J., Ashwal S., Franz D. Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-l-tryptophan. Epilepsia 1995, 36:783-791.
40. Richard O., Hevor T. Methionine sulfoximine increases acetylcholine level in the rat bra no relation with epileptogenesis. Neuroreport 1995, 6:2027-2032.
41. Rothstein J.D., Tabakoff B. Effects of the convulsant methionine sulfoximine on striatal dopamine metabolism. J. Neurochem. 1982, 39:452-457.
42. Tagliabracci V.S., Girard J.M., Segvich D., Meyer C., Turnbull J., Zhao X., Minassian B.A., Depaoli-Roach A.A., Roach P.J. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J. Biol. Chem. 2008, 283:33816-33825.
43. Toussi H.R., Schatz R.A., Waszczak B.L. Suppression of methionine sulfoximine seizures by intranigral gamma-vinyl GABA injection. Eur. J. Pharmacol. 1987, 137:261-264.
44. Trindade-Filho E.M., de Castro-Neto E.F., de A.C.R., Lima E., Scorza F.A., Amado D., Naffah-Mazzacoratti Mda G., Cavalheiro E.A. Serotonin depletion effects on the pilocarpine model of epilepsy. Epilepsy Res. 2008, 82:194-199.
45. Veltman D.J., Ruhe H.G., Booij J. Investigating serotonergic function using positron emission tomography: overview and recent findings. Curr. Pharm. Des. 2010, 16:1979-1989.
46. Verge V., Legrand A., Hevor T. Isolation of carbohydrate metabolic clones from cultured astrocytes. Glia 1996, 18:244-254.
47. Wakamoto H., Chugani D.C., Juhasz C., Muzik O., Kupsky W.J., Chugani H.T. Alpha-methyl-l-tryptophan positron emission tomography in epilepsy with cortical developmental malformations. Pediatr. Neurol. 2008, 39:181-188.
48. Wolfe L.S., Elliot K.A.C. Chemical studies in relation to convulsive conditions. Neurochemistry 1962, 694-727. Thomas Publisher, Springfield. K.A.C. Elliot, I.H. Page, J.H. Quastel (Eds.).